Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges
Neuroinflammation, α-synuclein pathology and dopaminergic cell loss are the hallmarks of Parkinson’s disease (PD), an incurable movement disorder. The presence of the blood-brain barrier (BBB) impedes the delivery of therapeutics and makes the design of drug-targeting delivery vehicles challenging....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Asian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087625000443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849246063309881344 |
|---|---|
| author | Jasleen Kaur Abhishek Thakran Saba Naqvi |
| author_facet | Jasleen Kaur Abhishek Thakran Saba Naqvi |
| author_sort | Jasleen Kaur |
| collection | DOAJ |
| description | Neuroinflammation, α-synuclein pathology and dopaminergic cell loss are the hallmarks of Parkinson’s disease (PD), an incurable movement disorder. The presence of the blood-brain barrier (BBB) impedes the delivery of therapeutics and makes the design of drug-targeting delivery vehicles challenging. Nanomedicine is designed and has significantly impacted the scientific community. Over the last few decades, to address the shortcomings of synthetic nanoparticles, a new approach has emerged that mimic the physiological environment. Cell membrane-coated nanoparticles have been developed to interact with the physiological environment, enhance central nervous system drug delivery and mask toxic effects. Cell membranes are multifunctional, biocompatible platforms with the potential for surface modification and targeted delivery design. A synchronous design of cell membrane and nanoparticles is required for the cell membrane-based biomimetics, which can improve the BBB recognition and transport. This review summarizes the challenges in drug delivery and how cell membrane-coated nanoparticles can overcome them. Moreover, major cell membranes used in biomedical applications are discussed with a focus on PD. |
| format | Article |
| id | doaj-art-ff3f384d769c41eea0f4a0abd6438689 |
| institution | Kabale University |
| issn | 1818-0876 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Pharmaceutical Sciences |
| spelling | doaj-art-ff3f384d769c41eea0f4a0abd64386892025-08-20T03:58:36ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762025-08-0120410106010.1016/j.ajps.2025.101060Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challengesJasleen Kaur0Abhishek Thakran1Saba Naqvi2Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Lucknow UP 226002, IndiaDepartment of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Lucknow UP 226002, IndiaDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Lucknow UP 226002, India; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Lucknow UP 226002, India; Corresponding author.Neuroinflammation, α-synuclein pathology and dopaminergic cell loss are the hallmarks of Parkinson’s disease (PD), an incurable movement disorder. The presence of the blood-brain barrier (BBB) impedes the delivery of therapeutics and makes the design of drug-targeting delivery vehicles challenging. Nanomedicine is designed and has significantly impacted the scientific community. Over the last few decades, to address the shortcomings of synthetic nanoparticles, a new approach has emerged that mimic the physiological environment. Cell membrane-coated nanoparticles have been developed to interact with the physiological environment, enhance central nervous system drug delivery and mask toxic effects. Cell membranes are multifunctional, biocompatible platforms with the potential for surface modification and targeted delivery design. A synchronous design of cell membrane and nanoparticles is required for the cell membrane-based biomimetics, which can improve the BBB recognition and transport. This review summarizes the challenges in drug delivery and how cell membrane-coated nanoparticles can overcome them. Moreover, major cell membranes used in biomedical applications are discussed with a focus on PD.http://www.sciencedirect.com/science/article/pii/S1818087625000443Parkinson’s diseaseCell membraneNanoparticlesBlood-brain barrierDrug delivery |
| spellingShingle | Jasleen Kaur Abhishek Thakran Saba Naqvi Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges Asian Journal of Pharmaceutical Sciences Parkinson’s disease Cell membrane Nanoparticles Blood-brain barrier Drug delivery |
| title | Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges |
| title_full | Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges |
| title_fullStr | Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges |
| title_full_unstemmed | Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges |
| title_short | Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges |
| title_sort | recent advances in cell membrane based biomimetic delivery systems for parkinson s disease perspectives and challenges |
| topic | Parkinson’s disease Cell membrane Nanoparticles Blood-brain barrier Drug delivery |
| url | http://www.sciencedirect.com/science/article/pii/S1818087625000443 |
| work_keys_str_mv | AT jasleenkaur recentadvancesincellmembranebasedbiomimeticdeliverysystemsforparkinsonsdiseaseperspectivesandchallenges AT abhishekthakran recentadvancesincellmembranebasedbiomimeticdeliverysystemsforparkinsonsdiseaseperspectivesandchallenges AT sabanaqvi recentadvancesincellmembranebasedbiomimeticdeliverysystemsforparkinsonsdiseaseperspectivesandchallenges |